Omeros (OMER) Research Hub

Omeros (OMER) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-10-26, shares last closed at 16.29 USD (-1.69%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E 7.57, market cap 0.70B. This hub links to the full technical, earnings and options research available for OMER.

Last updated 2026-10-26 · Source: end-of-day prices (adjusted); indicators computed by SniperIQ

SectorHealthcare (Biotechnology)
ExchangeNASDAQ, US
Last close16.29 USD (-1.69%)
52-week range7.39 USD – 21.24 USD
Trend regimeRange
14-day RSI35.2 (Bearish)
Trailing P/E7.57
Market cap0.70B
Dividend yield0.00%
Next earnings2026-08-13

Available research for OMER

Earnings

OMER earnings date and last-quarter result: next report 2026-08-13, last quarter beat, P/E 7.57. Updated 2026-07-23.

Options: Covered Call

Covered Call on OMER: how it works, illustrative setup around the real 16.29 USD price, max profit/loss, breakeven and when to use it. Educational.

Options: Iron Condor

Iron Condor on OMER: how it works, illustrative setup around the real 16.29 USD price, max profit/loss, breakeven and when to use it. Educational.

Options: Protective Put

Protective Put on OMER: how it works, illustrative setup around the real 16.29 USD price, max profit/loss, breakeven and when to use it. Educational.

Technical

OMER technical analysis: range, last 16.29 USD, RSI 35.2, 52w range 7.39 USD–21.24 USD, real support/resistance. Updated 2026-10-26.

More on SniperIQ

Frequently asked questions

What sector is OMER in?

Omeros (OMER) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.

Is OMER in an uptrend or downtrend?

As of 2026-10-26, OMER is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.

What is OMER's trailing P/E ratio?

OMER's trailing P/E is 7.57, with a market cap of 0.70B. See the earnings research page for full valuation detail.

When does OMER next report earnings?

OMER is next scheduled to report earnings on 2026-08-13.